{"entity":{"type":"insider","cik":"0001951287","url":"/insider/0001951287","json_url":"/insider/0001951287.json","name":"Karas Eric","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":7,"first":"2024-08-21","last":"2026-06-12","span_basis":"filed_date"},"name_variants":[{"name":"Karas Eric","source":"filing","n_filings":7,"first_seen":"2024-08-21","last_seen":"2026-06-12"}],"transactions":[{"id":5792678,"accession":"0001951287-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001951287-26-000004","line_url":"/filing/0001951287-26-000004#line-2","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001951287","owner_name":"Karas Eric","owner_display_name":"Karas Eric","owner_url":"/insider/0001951287","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","total_whole":"250,000","shares_owned_after":12176.0,"shares_owned_after_display":"12,176","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-12","filed_date":"2026-06-12","scope":"insider"},{"id":4641497,"accession":"0001415889-25-019321","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-019321","line_url":"/filing/0001415889-25-019321#line-2","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001951287","owner_name":"Karas Eric","owner_display_name":"Karas Eric","owner_url":"/insider/0001951287","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":16.9907,"price_display":"16.99","price_state":"stated","total_value":254860.5,"total_display":"254,860.50","total_whole":"254,861","shares_owned_after":10315.0,"shares_owned_after_display":"10,315","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-01","filed_date":"2025-07-03","scope":"insider"},{"id":4146683,"accession":"0001415889-25-017901","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-017901","line_url":"/filing/0001415889-25-017901#line-2","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001951287","owner_name":"Karas Eric","owner_display_name":"Karas Eric","owner_url":"/insider/0001951287","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":240000.0,"total_display":"240,000.00","total_whole":"240,000","shares_owned_after":7696.0,"shares_owned_after_display":"7,696","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-18","filed_date":"2025-06-20","scope":"insider"},{"id":4074507,"accession":"0001415889-25-008796","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-008796","line_url":"/filing/0001415889-25-008796#line-2","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001951287","owner_name":"Karas Eric","owner_display_name":"Karas Eric","owner_url":"/insider/0001951287","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":140000.0,"total_display":"140,000.00","total_whole":"140,000","shares_owned_after":7696.0,"shares_owned_after_display":"7,696","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-21","scope":"insider"},{"id":2864518,"accession":"0001415889-24-028349","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-028349","line_url":"/filing/0001415889-24-028349#line-4","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001951287","owner_name":"Karas Eric","owner_display_name":"Karas Eric","owner_url":"/insider/0001951287","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6283.0,"shares_display":"6,283","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":87962.0,"total_display":"87,962.00","total_whole":"87,962","shares_owned_after":5693.0,"shares_owned_after_display":"5,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-04","filed_date":"2024-12-04","scope":"insider"},{"id":2864511,"accession":"0001415889-24-028349","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-028349","line_url":"/filing/0001415889-24-028349#line-2","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001951287","owner_name":"Karas Eric","owner_display_name":"Karas Eric","owner_url":"/insider/0001951287","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3717.0,"shares_display":"3,717","price_per_share":14.1139,"price_display":"14.11","price_state":"stated","total_value":52461.3663,"total_display":"52,461.37","total_whole":"52,461","shares_owned_after":5693.0,"shares_owned_after_display":"5,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-02","filed_date":"2024-12-04","scope":"insider"},{"id":2486199,"accession":"0001415889-24-023712","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-023712","line_url":"/filing/0001415889-24-023712#line-2","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001951287","owner_name":"Karas Eric","owner_display_name":"Karas Eric","owner_url":"/insider/0001951287","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":140000.0,"total_display":"140,000.00","total_whole":"140,000","shares_owned_after":5693.0,"shares_owned_after_display":"5,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-18","filed_date":"2024-09-19","scope":"insider"},{"id":3177926,"accession":"0001415889-24-021885","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-021885","line_url":"/filing/0001415889-24-021885#line-2","is_derivative":false,"issuer_cik":"0001671858","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001671858","owner_cik":"0001951287","owner_name":"Karas Eric","owner_display_name":"Karas Eric","owner_url":"/insider/0001951287","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":140000.0,"total_display":"140,000.00","total_whole":"140,000","shares_owned_after":5693.0,"shares_owned_after_display":"5,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-19","filed_date":"2024-08-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001671858","name":"ARS Pharmaceuticals, Inc.","url":"/issuer/0001671858","role":"Officer (Chief Commercial Officer)","n_filings":7,"first_seen":"2024-08-21","last_seen":"2026-06-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001951287","retrieved_at":"2026-08-26T03:00:21+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}